In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.

MLA

Hao, Xiao-Ke, et al. “In Vitro and in Vivo Prodrug Therapy of Prostate Cancer Using Anti-Gamma-Sm-ScFv/HCPA Fusion Protein.” The Prostate, vol. 66, no. 8, June 2006, pp. 858–66. EBSCOhost, https://doi.org/10.1002/pros.20402.

APA

Hao, X.-K., Liu, J.-Y., Yue, Q.-H., Wu, G.-J., Bai, Y.-J., & Yin, Y. (2006). In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein. The Prostate, 66(8), 858–866. https://doi.org/10.1002/pros.20402

Chicago

Hao, Xiao-Ke, Jia-Yun Liu, Qiao-Hong Yue, Guo-Jun Wu, Yu-Jie Bai, and Ying Yin. 2006. “In Vitro and in Vivo Prodrug Therapy of Prostate Cancer Using Anti-Gamma-Sm-ScFv/HCPA Fusion Protein.” The Prostate 66 (8): 858–66. doi:10.1002/pros.20402.